{"nct_id":"NCT00210834","title":"An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy.","status":"COMPLETED","status_verified_date":"2010-05","start_date":"2004-05","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2005-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}